Home
Conditions
Neoplastic Processes

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,272 public trials 686 recruiting studies

Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Abiraterone Acetate in Molecular Apocrine Breast Cancer

NCT01842321

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: Ico - Site Paul Papin Angers, France

Institut Sainte Catherine Avignon, France

Chu - Hopital Jean Minjoz Besançon, France

Institut Bergonie Bordeaux, France

View all 36 locations

View Trial Details

Completed

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

NCT01327612

Conditions: Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +44 more
Locations: Research Site Duarte, California, United States

Research Site La Jolla, California, United States

Research Site Denver, Colorado, United States

Research Site Tampa, Florida, United States

View Trial Details

Completed

Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas

NCT03489369

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States

The University of Texas MD Anderson Cancer Center Houston, Texas, United States

Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Completed

Safety Study of Adoptive Transfer of Autologous IKDC-like Cells

NCT02661685

Conditions: Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +2 more
Locations: Tri-Service General Hospital Taipei, Taiwan

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

NCT00006050

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +16 more
Locations: Institut J. Paoli and I. Calmettes Marseille, France

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France

Institut Gustave Roussy Villejuif, France

View Trial Details

Completed

Whole-Exome Sequencing (WES) of Cancer Patients

NCT02127359

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +22 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Insitute Boston, Massachusetts, United States

View Trial Details

Completed

Study of the Impact of Everolimus Treatment on Lymphocytes NK (Natural Killer) Development and Functions for Patients With a Metastatic Breast Cancer (HR+ / HER2/Neu Negative)

NCT02536625

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: Centre Leon Berard Lyon, France

Centre Hospitalier Lyon Sud Pierre-Bénite, France

View Trial Details

Completed

Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer

NCT02139358

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations: Hackensack University Medical Center Hackensack, New Jersey, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma

NCT01833520

Conditions: Disease Attributes, Neoplasm Metastasis, Neoplasms, +10 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Neoplastic Processes

Neoplastic Processes trial results

Related conditions